Inventor · disambiguated record
Beverly Koller
Also filed as: KOLLER BEVERLY · KOLLER BEVERLY H
12 granted patents·3 pending applications·1,026 citations·filing 1985–2022
93Inventor score
Top patents by PatentIndex Score
15 records- 0198US5413923AHomologous recombination for universal donor cells and chimeric mammalian hostsCELL GENESYS INC·Filed 1992·Granted May 9, 1995·648 cites·12 claims
- 0293US10857202B2Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptorsPIERIS PHARMACEUTICALS GMBH·Filed 2019·Granted Dec 8, 2020·4 cites·18 claims
- 0392US11382951B2Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptorsPIERIS PHARMACEUTICALS GMBH·Filed 2020·Granted Jul 12, 2022·2 cites·19 claims
- 0491US6514752B1Homologous recombination for universal donor cells and chimeric mammalian hostsCELL GENESYS INC·Filed 1995·Granted Feb 4, 2003·60 cites·14 claims
- 0591US5574205AHomologous recombination for universal donor cells and chimeric mammalian hostsCELL GENESYS·Filed 1993·Granted Nov 12, 1996·114 cites·8 claims
- 0690US10016483B2Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptorsPIERIS PHARMACEUTICALS GMBH·Filed 2016·Granted Jul 10, 2018·6 cites·20 claims
- 0790US6139835AHomologous recombination for allogeneic donor cellsCELL GENESYS INC·Filed 1995·Granted Oct 31, 2000·54 cites·62 claims
- 0887US10398754B2Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptorsPIERIS PHARMACEUTICALS GMBH·Filed 2018·Granted Sep 3, 2019·4 cites·19 claims
- 0984US5416260AHomologous recombination for universal donor cells and chimeric mammalian hostsUNIV NORTH CAROLINA·Filed 1990·Granted May 16, 1995·97 cites·5 claims
- 1083US9572863B2Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptorsPIERIS PHARMACEUTICALS GMBH·Filed 2012·Granted Feb 21, 2017·4 cites·20 claims
- 1179US2023021168A1Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptorsPIERIS PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 1271US4835098ACharacterization of HLA alleles with locus-specific DNA probesUNIV MINNESOTA·Filed 1985·Granted May 30, 1989·32 cites·19 claims
- 1355US6677501B2P2X7 receptor-deficient mice and uses thereofPFIZER·Filed 2001·Granted Jan 13, 2004·1 cites·6 claims
- 1448US2005090003A1P2x7 receptor-deficient non-human animals and uses thereofPFIZER INC UNIVERSITY OF NORTH·Filed 2003·Application pending·0 cites
- 1545US2009203547A1Gene and Cognate Protein Profiles and Methods to Determine Connective Tissue Markers in Normal and Pathologic ConditionsBANES ALBERT·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Beverly Koller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →